Efficacy of Inactivated Vaccine in Preventing Antigenically Drifted Influenza Type A and Well-Matched Type B

JAMA: The Journal of the American Medical Association

Volumn 272, Issue 14, 1994, Pages 1122-1126

  Sugaya, Norio ^a   Nerome, Kuniaki ^b   Ishida, Masatoshi ^b   Miyako, ^b  

^a NIPPON KOKAN HOSPITAL   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE VACCINE;

ARTICLE; ASTHMA; BACTERIAL INFECTION; CHILD; EPIDEMIC; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS INFLUENZAE TYPE A; HAEMOPHILUS INFLUENZAE TYPE B; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; JAPAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; VACCINATION; VIRUS ISOLATION;

EID: 84942947742     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1994.03520140052037     Document Type: Article

References (17)

1. Dowdle WR, Millar JD, Schonberger LB, Ennis FA, La Montagne JR. Influenza immunization policies and practices in Japan. J Infect Dis. 1980;141: 258-264.
2. Oya A, Nerome K. Experiences with mass vaccination of young age groups with inactivated vaccines. In: Kendal AP, Patriarca AP, eds. Options for the Control of Influenza, 1986. New York, NY: Alan R. Liss Inc; 1986:183-192.
3. Monto AS, Davenport FM, Napier JA, Francis T Jr. Modification of an outbreak of influenza in Tecumseh, Michigan, by vaccination of schoolchildren. J Infect Dis. 1970;122:16-25.
4. Centers for Disease Control and Prevention. Update: influenza activity—United States, 1992-93 season. MMWR Morb Mortal Wkly Rep. 1993;42:385-387.
5. Stiver HG, Graves P, Eickhoff TC, Meiklejohn G. Efficacy of ‘Hong Kong’ vaccine in preventing ‘England’ variant influenza A in 1972. N Engl J Med. 1973;289:1267-1271.
6. Meiklejohn G, Eickhoff TC, Graves P, Josephine I. Antigenic drift and efficacy of influenza vaccines, 1976-1977. J Infect Dis. 1978;138:618-624.
7. Gross PA, Ennis FA, Gaerlan PF, Denson LJ, Denning CR, Schiffmann D. A controlled double-blind comparison of reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children. J Infect Dis. 1977;136:623-632.
8. Wright PF, Dupont W, Edwards K. Comparative efficacy of cold-adapted and inactivated vaccines. In: Hannoun C, Kendal AP, Klenk HD, Ruben FL, eds. Options for the Control of Influenza 2. Amsterdam, the Netherlands: Excerpta Medica/ Elsevier Science Publishers BV; 1993:71-77.
9. Feery BJ, Evered MG, Hayes K. Homologous and heterologous antibody responses to subunit influenza virus vaccine. J Hyg Lond. 1978;81:331-336.
10. Wright PF, Bryant JD, Karzon DT. Comparison of influenza B/Hong Kong virus infections among infants, children, and young adults. J Infect Dis. 1980;141:430-435.
11. Kanegae Y, Sugita S, Endo A, et al. Evolutionary pattern of the hemagglutinin gene of influenza B viruses isolated in Japan: cocirculating lineages in the same epidemic season. J Virol. 1990;64:2860-2865.
12. Foy HM, Cooney MK, Allan ID, Frost F, Blumhagen JM, Fox JP. Influenza B virus vaccines in children and adults. J Infect Dis. 1981;143:700-706.
13. Fox JP, Cooney MK, Hall CE, Foy HM. Influenza virus infections in Seattle families, 1975-1979, II: pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness. Am J Epidemiol. 1982;116:228-242.
14. Sugaya N, Nerome K, Ishida M, et al. Impact of influenza virus infection as a cause of pediatric hospitalization. J Infect Dis. 1992;165:373-375.
15. Heilman C, La Montagne JR. Influenza: status and prospects for its prevention, therapy, and control. Pediatr Clin North Am. 1990;37:669-688.
16. Gruber WC, Kirschner K, Tollefson S, et al. Comparison of monovalent and trivalent live attenuated influenza vaccines in young children. J Infect Dis. 1993;168:53-60.
17. Rudenko LG, Slepushkin AN, Monto AS, et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Infect Dis. 1993;168:881-887.